Literature DB >> 35968336

Prognostic impact of the preoperatory neutrophil/lymphocyte index on early surgical complications of patients with colorectal cancer.

Ignacio Escobar-Munguía1, Ricardo Berea-Baltierra2, Ángel Morales-González3, Eduardo Madrigal-Santillán4, Liliana Anguiano-Robledo5, José A Morales-González4.   

Abstract

Colorectal cancer (CRC) is found among those with greatest frequency and exponential increase worldwide, with high mortality rates, which are observed as increasing due to the postsurgical complications that come to present. Systemic inflammation participates in the development and progression of cancer; therefore, inflammatory and/or immunological response markers such as the neutrophil/lymphocyte index (NLI) can aid us in predicting the poor results of our interventions. The purpose of our study was to determine the impact of an NLI of ≥2.6 as a predictor of early postsurgical complications. By means of a prospective cohort, we analyzed 158 patients with CRC who were submitted to elective surgery with a later 30-day follow-up. We found that the preoperatory NLI of ≥2.6 obtained an odds ratio (OR) = 2.24 (95% confidence interval [CI], 1.15-4.36) as a prognostic factor of early postsurgical complications according to the Clavien-Dindo classification scale, which represents a low prognostic impact due to its predictive yield with low accuracy, which is the opposite of what other reports have previously published. The use of chemotherapy before the surgical procedure was also determined to be a risk factor for post-surgical complications. AJCR
Copyright © 2022.

Entities:  

Keywords:  Neutrophils; colorectal neoplasms; lymphocytes; postoperatory complications

Year:  2022        PMID: 35968336      PMCID: PMC9360242     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   5.942


  20 in total

1.  Comparison of Hematologic and Other Prognostic Markers in Metastatic Colorectal Cancer.

Authors:  Joey Mercier; Ioannis A Voutsadakis
Journal:  J Gastrointest Cancer       Date:  2019-09

Review 2.  Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.

Authors:  Jun Zheng; Jianye Cai; Hui Li; Kaining Zeng; Liying He; Hongyuan Fu; Jiebin Zhang; Liang Chen; Jia Yao; Yingcai Zhang; Yang Yang
Journal:  Cell Physiol Biochem       Date:  2017-11-27

3.  [An elevated neutrophil/lymphocyte ratio is associated with poor prognosis in stage II resected colon cancer].

Authors:  Gonzalo I Urrejola; Claudia E Bambs; Manuel A Espinoza; José Gellona; Alvaro M Zúñiga; María Elena Molina; Felipe Bellolio; Rodrigo Miguieles; James M Campbell; George A Pinedo
Journal:  Rev Med Chil       Date:  2013-05       Impact factor: 0.553

4.  Neutrophil-lymphocyte ratio and nutritional status are clinically useful in predicting prognosis in colorectal cancer patients.

Authors:  Thiago Huaytalla Silva; Arthur Orlando Corrêa Schilithz; Wilza Arantes Ferreira Peres; Leonardo Borges Murad
Journal:  Nutr Cancer       Date:  2019-10-30       Impact factor: 2.900

5.  The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.

Authors:  Yongxi Song; Yuchong Yang; Peng Gao; Xiaowan Chen; Dehao Yu; Yingying Xu; Junhua Zhao; Zhenning Wang
Journal:  BMC Cancer       Date:  2017-11-10       Impact factor: 4.430

6.  Predictors of one and two years' mortality in patients with colon cancer: A prospective cohort study.

Authors:  José M Quintana; Ane Antón-Ladislao; Nerea González; Santiago Lázaro; Marisa Baré; Nerea Fernández-de-Larrea; Maximino Redondo; Eduardo Briones; Antonio Escobar; Cristina Sarasqueta; Susana García-Gutierrez; Inmaculada Aróstegui
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

7.  Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) study.

Authors:  Andrea Casadei-Gardini; Emanuela Scarpi; Paola Ulivi; Maria Angela Palladino; Caterina Accettura; Ilaria Bernardini; Andrea Spallanzani; Fabio Gelsomino; Jody Corbelli; Giorgia Marisi; Silvia Ruscelli; Martina Valgiusti; Giovanni Luca Frassineti; Alessandro Passardi
Journal:  Cancer Manag Res       Date:  2019-05-10       Impact factor: 3.989

8.  Multimodal prehabilitation in colorectal cancer patients to improve functional capacity and reduce postoperative complications: the first international randomized controlled trial for multimodal prehabilitation.

Authors:  Stefanus van Rooijen; Francesco Carli; Susanne Dalton; Gwendolyn Thomas; Rasmus Bojesen; Morgan Le Guen; Nicolas Barizien; Rashami Awasthi; Enrico Minnella; Sandra Beijer; Graciela Martínez-Palli; Rianne van Lieshout; Ismayil Gögenur; Carlo Feo; Christoffer Johansen; Celena Scheede-Bergdahl; Rudi Roumen; Goof Schep; Gerrit Slooter
Journal:  BMC Cancer       Date:  2019-01-22       Impact factor: 4.430

9.  Immune cell concentrations among the primary tumor microenvironment in colorectal cancer patients predicted by clinicopathologic characteristics and blood indexes.

Authors:  Guifang Guo; Yixing Wang; Yixin Zhou; Qi Quan; Yijun Zhang; Haohua Wang; Bei Zhang; Liangping Xia
Journal:  J Immunother Cancer       Date:  2019-07-12       Impact factor: 13.751

10.  Low Serum Ionized Calcium, Elevated High-Sensitivity C-Reactive Protein, Neutrophil-Lymphocyte Ratio, and Body Mass Index (BMI) Are Risk Factors for Severe Acute Pancreatitis in Patients with Hypertriglyceridemia Pancreatitis.

Authors:  Shanshan Yu; Dong Wu; Kui Jin; Lu Yin; Yangyang Fu; Danyu Liu; Lili Zhang; Xuezhong Yu; Jun Xu
Journal:  Med Sci Monit       Date:  2019-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.